Penny Stock Alert: Buy Rating Issued To InSite Vision (INSV)

One biotech penny stock to watch that made significant strides last year to position their company as a leading global developer of ophthalmic therapeutics for front-of-eye conditions is OTCBB listed InSite Vision, Inc. (OTCBB: INSV.OB). Their strides have caught the attention of one of Wall Street’s leading analysts, Roth Capital, who yesterday issued a “buy” rating on the biotech ...

Continue Reading →
0

Cannabis Science Presents Visuals Of Cancer Tumors Dying

Cannabis Science, Inc. (OTCBB: CBIS.OB), a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, shared new photographs from this cancer patient with severe squamous cell carcinoma.

These pictures clearly show that this patient, with previously treatment-resistant tumors, continues to make obvious improvement. The tumors appear to be dying and ...

Continue Reading →
0